Cheng Yang
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 8
- Cancer, Hypoxia, and Metabolism 7
Cheng Yang
159 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 129
- Molecular Medicine 252
- Cancer Research 747
- Molecular Biology 2.1k
- Infectious Diseases 420
- Pharmacology 194
Countries citing papers authored by Cheng Yang
This map shows the geographic impact of Cheng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Yang more than expected).
Fields of papers citing papers by Cheng Yang
This network shows the impact of papers produced by Cheng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Yang. The network helps show where Cheng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 5 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 6 | |
| 11 | 2022 | 60 | |
| 12 | 2021 | 18 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 18 | |
| 15 | 2021 | 40 | |
| 16 | 2020 | 25 | |
| 17 | 2019 | 35 | |
| 18 | 2018 | 260 | |
| 19 | 2018 | 51 | |
| 20 | Experimental study of the effect of IH764-3 on pulmonary fibrosis. | 1993 | 2 |
About Cheng Yang
Cheng Yang is a scholar working on Cancer Research, Toxicology, Pulmonary and Respiratory Medicine, Molecular Biology and Molecular Medicine, having authored 164 papers that have together received 4.1k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (36 papers), Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers), Natural product bioactivities and synthesis (8 papers), Eosinophilic Disorders and Syndromes (7 papers), Peptidase Inhibition and Analysis (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Protein Degradation and Inhibitors (7 papers). The work is most often cited by research in Molecular Medicine (252 citations), Cancer Research (747 citations), Molecular Biology (2.1k citations), Infectious Diseases (420 citations) and Pharmacology (194 citations). Cheng Yang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Honggang Zhou, Tao Sun, Shuang Chen, Weilong Zhong, Yanrong Liu, Huijuan Liu, Yuan Qin, Xiaohe Li, Yu Guo and Jing Meng. Their work appears in journals such as International Immunopharmacology, Frontiers in Pharmacology, Oncotarget, Theranostics and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.